Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus
出版年份 2017 全文链接
标题
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus
作者
关键词
-
出版物
XENOBIOTICA
Volume 48, Issue 1, Pages 89-108
出版商
Informa UK Limited
发表日期
2016-12-25
DOI
10.1080/00498254.2016.1275063
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models
- (2016) Manthena V. Varma et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Absence of Drug–Drug Interactions Between Luseogliflozin, a Sodium–Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males
- (2015) Takashi Sasaki et al. ADVANCES IN THERAPY
- Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review
- (2015) Shashank R Joshi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effects of miglitol, sitagliptin, and initial combination therapy with both on plasma incretin responses to a mixed meal and visceral fat in over-weight Japanese patients with type 2 diabetes. “The MASTER randomized, controlled trial”
- (2014) Atsushi Mikada et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination
- (2014) Yuri Ono et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of voglibose in type 2 diabetes
- (2014) Kohei Kaku EXPERT OPINION ON PHARMACOTHERAPY
- The effect of voglibose on the pharmacokinetics of metformin in healthy Korean subjects
- (2014) Ho-Sook Kim et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects
- (2014) S. Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Simultaneous Quantification of Aliskiren, Valsartan and Sitagliptin by LC with Fluorescence Detection: Evidence of Pharmacokinetic Interaction in Rats
- (2013) Vishal Goyani et al. CHROMATOGRAPHIA
- Pharmacokinetic and pharmacodynamic interaction of vildagliptin and voglibose in Japanese patients with Type 2 diabetes
- (2013) Masayuki Yamaguchi et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Impact of Voglibose on the Pharmacokinetics of Dapagliflozin in Japanese Patients with Type 2 Diabetes
- (2013) Akira Imamura et al. Diabetes Therapy
- Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
- (2011) Sabine Klatt et al. Pharmaceutics
- Reduction of the acute bioavailability of metformin by the α-glucosidase inhibitor acarbose in normal man
- (2010) A. J. SCHEEN et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions
- (2009) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- The Drug Transporter−Metabolism Alliance: Uncovering and Defining the Interplay
- (2009) Leslie Z. Benet MOLECULAR PHARMACEUTICS
- Interplay of Transporters and Enzymes in Drug and Metabolite Processing
- (2009) K. Sandy Pang et al. MOLECULAR PHARMACEUTICS
- Prediction of pharmacokinetic drug–drug interaction caused by changes in cytochrome P450 activity using in vivo information
- (2009) Akihiro Hisaka et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More